Health
Vaccine experts meeting over clot report – The Young Witness
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General12 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals